Author:
Leblebicioglu Hakan,Arends Joop E.,Ozaras Resat,Corti Giampaolo,Santos Lurdes,Boesecke Christoph,Ustianowski Andrew,Duberg Ann-Sofi,Ruta Simona,Salkic Nermin N.,Husa Petr,Lazarevic Ivana,Pineda Juan A.,Pshenichnaya Natalia Yurievna,Tsertswadze Tengiz,Matičič Mojca,Puca Edmond,Abuova Gulzhan,Gervain Judit,Bayramli Ramin,Ahmeti Salih,Koulentaki Mairi,Kilani Badreddine,Vince Adriana,Negro Francesco,Sunbul Mustafa,Salmon Dominique
Reference23 articles.
1. (access-to-hepatitis-C-treatment/page/3060907/">http://www.aidsmap.com/France-to-provide-universal-access-to-hepatitis-C-treatment/page/3060907/) (accessed at 1 July 2016).
2. Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment;Bouscaillou;Int J. Drug Policy,2014
3. Center for Disease Analysis report, available at: http://centerforda.com/fact_files.htm (accessed at 1 July 2016).
4. Progress toward prevention and control of hepatitis C virus infection–Egypt, 2001-2012;Centers for Disease Control and Prevention (CDC);MMWR Morb. Mortal. Wkly. Rep.,2012
5. Economic and public health impacts of policies restricting access to hepatitis C treatment for Medicaid patients;Chidi;Value Health,2016